CIK 0001630627
- Accelerated filer
TREACE MEDICAL CONCEPTS, INC.
Sign in to watch- Ticker
- TMCI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 471052611
- Phone
- +1 904-373-5940
- Business address
- 100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
- Open-market buys, last 90 days
- $246,654
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$246,654. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-24 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −207 | 634,656 | ||
| 2026-08-09 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −9,814 | 679,863 | ||
| 2026-03-10 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −1,396 | 704,677 | ||
| 2026-03-08 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −401 | 706,073 | ||
| 2026-02-10 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion | +16,875 | $1.05 | $18K | 706,474 |
| 2026-02-10 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) | −16,875 | 0 | ||
| 2026-01-22 | Scanlan Sean F. Chief Innovation Officer | Grant or award | +262,500 | 689,599 | ||
| 2026-01-21 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion | +53,500 | $0.72 | $39K | 427,099 |
| 2026-01-21 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) | +53,500 | 0 | ||
| 2025-10-24 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −208 | 373,599 | ||
| 2025-08-09 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −9,814 | 373,807 | ||
| 2025-07-18 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion | +33,437 | $0.72 | $24K | 383,621 |
| 2025-07-18 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) | −33,437 | 0 | ||
| 2025-03-17 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion 10b5-1 | +50,000 | $1.05 | $53K | 414,081 |
| 2025-03-17 | Scanlan Sean F. Chief Innovation Officer | Sale 10b5-1 | −50,000 | $7.97 | $398K | 364,081 |
| 2025-03-17 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −50,000 | 16,875 | ||
| 2025-03-10 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −1,396 | 364,081 | ||
| 2025-03-08 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −401 | 365,477 | ||
| 2025-01-22 | Scanlan Sean F. Chief Innovation Officer | Grant or award | +140,625 | 365,878 | ||
| 2025-01-10 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −4,821 | 225,253 |
Page 1 of 3 · 45 trades